Skip to main content
Premium Trial:

Request an Annual Quote

The Low-Down on AACC

Our sister blog, The Sample, is hard at work covering the AACC annual meeting. Kirell Lakhman has a series of posts up and from Friday's session, he writes about new molecular techs flocking to pharma and linking oxaliplatin toxicity to the glutathione S-transferase gene. Yesterday, Lakhman blogged about what molecular diagnostic labs should keep in mind when trying to quantify serum tumor markers using LC-MS/MS and how revamping the US health care system may affect clinical labs. Lakhman is also noting interesting quotes he's heard, such as the University of Washington's Andrew Hoofnagle saying the software bundle to a mass spec "can be testy at times." If you've heard anything good, let him know.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.